NCT03426748View on ClinicalTrials.gov

LDR vs. HDR Brachytherapy for Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions
Prostate Cancer
Interventions
RADIATION

Low dose rate prostate brachytherapy

Permanent implantation of radioactive Iodine-125 seeds under anesthesia with ultrasound guidance

RADIATION

High dose rate prostate brachytherapy

Temporary implantation of radioactive material into the prostate in the form of a stepping source of Iridium 192 that travels through 16-18 needles or catheters strategically placed through the prostate

Trial Locations (1)

V1Y5L3

British Columbia Cancer Agency Center for the Southern Interior, Kelowna

All Listed Sponsors
collaborator

BC Cancer Foundation

OTHER

lead

British Columbia Cancer Agency

OTHER

NCT03426748 - LDR vs. HDR Brachytherapy for Prostate Cancer | Biotech Hunter | Biotech Hunter